Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2008, European Journal of Cardio-Thoracic Surgery
…
3 pages
1 file
Arrhythmogenic right ventricular dysplasia (ARVD) encompasses a spectrum of presentations including ventricular tachycardia, sudden cardiac death and heart failure. Complete right ventricular disarticulation was effective in a young athletic male who was refractory to drug therapy and experienced recurrent shock therapies from an implantable cardioverter-defibrillator that were incapacitating. The case highlights the challenging management of ARVD despite over two decades of research and the resurgent interest in ventricular disarticulation.
Minerva cardioangiologica, 2014
Journal of cardiology, 2015
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited genetic disease caused by defective desmosomal proteins, and it has typical histopathological features characterized by predominantly progressive fibro-fatty infiltration of the right ventricle. Clinical presentations of ARVD/C vary from syncope, progressive heart failure (HF), ventricular tachyarrhythmias, and sudden cardiac death (SCD). The 2010 modified Task Force criteria were established to facilitate the recognition and diagnosis of ARVD/C. An implantable cardiac defibrillator (ICD) remains to be the cornerstone in prevention of SCD in patients fulfilling the diagnosis of definite ARVD/C, especially among ARVD/C patients with syncope, hemodynamically unstable ventricular tachycardia (VT), ventricular fibrillation, and aborted SCD. Further risk stratification is clinically valuable in the management of patients with borderline or possible ARVD/C and mutation carriers of family members. However, g...
Annual Review of Medicine, 1999
Background-Arrhythmogenic right ventricular dysplasia (ARVD) is an inherited cardiomyopathy characterized by right ventricular dysfunction and ventricular arrhythmias. The purpose of our study was to describe the presentation, clinical features, survival, and natural history of ARVD in a large cohort of patients from the United States. Methods and Results-The patient population included 100 ARVD patients (51 male; median age at presentation, 26
Heart, 1993
Right ventricular dysplasia is a little understood condition and is almost certainly underdiagnosed as an important cause of recurrent ventricular tachycardia and sudden death. This report describes two patients with right ventricular dysplasia. Their clinical presentation reflects the remarkable diversity of the disease while the potentially lifethreatening nature of their arrhythmias and their lack of response to medical treatment justified the antiarrhythmic surgical procedure of right ventricular disarticulation. (Br Heart J 1993;69:158-160)
Korean Circulation Journal, 2008
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is characterized by progressive, fibrofatty replacement of the myocardium, ventricular arrhythmia, sudden death, and progressive heart failure. ARVC/D may be an important cause of syncope, ventricular arrhythmias, electrocardiogram (ECG) abnormalities and/or non-ischemic wall motion abnormalities. Some patients, however, do not have a typical clinical presentation. Thus, a high clinical suspicion and extensive studies may be needed to establish the diagnosis of ARVC/D. Recent progress in diagnostic modalities and a better understanding of the clinical manifestations of ARVC/D may lead to optimal management of affected patients.
2015
Arrhythmogenic right ventricular cardiomyopathy/ dysplasia (ARVC/D), mostly affecting young/middle-aged individuals, poses a significant risk of malignant ventricular arrhythmias (VAs) and subsequent sudden cardiac death (SCD). Antiarrhythmic agents (AAA) provide insufficient arrhythmia suppression and prevention and can be proarrhythmic. Thus, the implantable cardioverters-defibrillator (ICD) is considered the first-line treatment, especially in patients with secondary prevention indication. Nevertheless, catheter ablation is an additional therapy to the ICD which has proved its efficacy in primary and secondary prevention of fatal arrhythmias and sudden cardiac death. The superiority of the combined endo- and epicardial VT ablation in this population is clear since the ARVC/D substrate has been shown to be mostly epicardial. Due to progressive nature of ARVC/D, ablation seems to be a useful tool for the patients who experience recurrent VT episodes or electrical storms.
2010
The aim of this study was to assess the outcome of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) patients treated with an implantable cardioverterdefibrillator (ICD). BACKGROUND Arrhythmogenic right ventricular dysplasia/cardiomyopathy is associated with tachyarrhythmia and an increased risk of sudden death. METHODS This study included 42 ARVD/C patients with ICDs (52% male, age 6 to 69 years, median 37 years) followed at our center. RESULTS Mean follow-up was 42 Ϯ 26 months (range 4 to 135 months). Complications associated with ICD implantation included need for lead repositioning (n ϭ 3) and system infection (n ϭ 2). During follow-up, one patient died of a brain malignancy and one had heart transplantation. Lead replacement was required in six patients as a result of lead fracture and insulation damage (n ϭ 4) or change in thresholds (n ϭ 2). During this period, 33 of 42 (78%) patients received a median of 4 (range 1 to 75) appropriate ICD interventions. The median period between ICD implantation and the first firing was 9 months (range 0.1 to 66 months). The ICD firing storms were observed in five patients. Inappropriate interventions were seen in 10 patients. Predictors of appropriate firing were induction of ventricular tachycardia (VT) during electrophysiologic study (EPS) (84% vs. 44%, p ϭ 0.024), detection of spontaneous VT (70% vs. 15%, p ϭ 0.001), male versus female gender (91% vs. 65%, p ϭ 0.04), and severe right ventricular dilation (39% vs. 0%, p ϭ 0.013). Using multivariate analysis, VT induction during EPS was associated with increased risk for firing in ARVD/C patients; odds ratio 11.2 (95% confidence interval 1.23 to 101.24, p ϭ 0.031). CONCLUSIONS Patients with ARVD/C have a high arrhythmia rate requiring appropriate ICD interventions. The ICD therapy appears to be well tolerated and important in the management of patients with ARVD/C.
Journal of Cardiovascular Electrophysiology, 2010
is a genetically determined myocardial disease characterized by fibrofatty replacement of the right ventricular wall. Ventricular tachyarrhythmias can be seen in the early stages of the disease, which is one of the most important causes of sudden death in young healthy individuals. Radiofrequency (RF) catheter ablation is an option for the treatment of medically refractory ventricular arrhythmias and it has shown to successfully abolish recurrent ventricular tachycardias (VT) as well as reduce the frequency in defibrillator therapies. However, variable acute and long-term success rates have been reported. The current mapping and ablation techniques include activation and entrainment mapping during tolerated VT and substrate ablation using 3-dimensional electroanatomic mapping systems. This article aims at providing a comprehensive review of RF catheter ablation of ventricular arrhythmias in the context of ARVD. (J Cardiovasc Electrophysiol, Vol. 21, pp. 473-486, April 2010) arrhythmogenic right ventricular dysplasia, right ventricular cardiomyopathy, ventricular tachycardia, catheter ablation
Anuario Colombiano de Historia Social y de la Cultura, 2012
Civil Engineering and Architecture, 2022
C.A.O.S. (Contemporary Africa on Screen), 2011
The Nucleus, 2018
Trans/Form/Ação, Marília, v. 46, n. 3, p. 127-152, Jul./Set., 2023
Advanced Synthesis & Catalysis, 2016
Annals of Surgery, 2009
Biotechnology and Bioengineering, 2002
Acta Physica Polonica A, 2012
ID on line REVISTA DE PSICOLOGIA, 2018
Abu Dhabi International Petroleum Exhibition & Conference, 2018
Tunjuk Ajar: Jurnal Penelitian Ilmu Pendidikan, 2019
The World Wide Web Conference on - WWW '19, 2019